FDC Ltd.

•

fdcindia.comBSE: 531599NSE: FDC

Market Cap₹ 5,579 Cr.

Current Price

High / Low₹ 528 / 313

Stock P/E18.9

Book Value₹ 161

Price to Book2.81

Dividend Yield0.00 %

ROCE17.0 %

ROE12.5 %

Face Value₹ 1

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Company is almost debt free
Company generates healthy free cash flow

CONS

A large part of profit comes from other income (28.7% of PBT)
Recent results are weak - TTM profit is down 10.7% versus prior year
Company has delivered a poor profit growth of 2.1% over past five years
Operating margins have contracted to 15.0% from 20.8%
Expensive relative to growth - PEG of 2.5

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	SUNPHARMA	1899.00	37.67	455633.71	0.84	2901.23	26.53	15299.88	10.98	19.11	28.81
2.	DIVISLAB	9100.00	82.59	241576.41	0.33	902.00	65.50	3080.00	27.80	21.51	40.75
3.	TORNTPHARM	4850.00	84.58	184478.41	0.78	566.00	3.28	4921.00	57.32	19.27	33.81
4.	CIPLA	1385.00	33.19	111888.39	0.94	785.55	-39.18	7119.28	4.13	16.00	16.73
5.	ZYDUSLIFE	1121.00	24.78	111820.18	0.09	990.20	-34.90	8017.00	23.97	21.39	24.54
6.	LAURUSLABS	1840.00	90.93	99417.45	0.11	362.07	123.94	2026.31	29.10	18.20	31.50
7.	LUPIN	2111.00	17.46	96528.82	0.85	1416.98	16.01	8276.89	34.28	28.86	29.59
8.	DRREDDY	1154.00	29.89	96322.06	0.69	435.60	-69.10	8099.80	-5.21	13.75	10.63
9.	MANKIND	2328.55	47.09	96179.61	0.04	574.09	29.12	4030.59	12.89	13.24	26.30
10.	AUROPHARMA	1653.30	25.62	95127.23	0.24	1032.03	25.22	9150.35	17.44	12.76	20.54
11.	GLENMARK	2427.00	38.10	68495.93	0.10	482.83	927.88	4018.48	31.35	20.35	20.03
12.	FDC	342.65	19.07	5578.69	0.00	132.49	9.18	667.69	2.97	16.52	21.42

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	530	480	452	454	624	505	459	482	642	462	458	564	655
	410	401	370	396	482	433	413	429	501	427	408	453	528
Operating Profit	120	79	82	58	142	72	46	53	141	35	50	112	127
OPM %	22.64%	16.41%	18.11%	12.73%	22.70%	14.33%	10.01%	10.96%	22.00%	7.56%	10.83%	19.78%	19.38%
	30	27	25	21	28	35	19	31	36	21	1	47	47
Interest	1	1	1	1	1	1	1	1	1	1	1	2	1
Depreciation	10	10	10	10	11	14	13	16	15	15	15	14	15
Profit before Tax	139	95	96	67	158	92	50	68	161	39	35	143	174
Tax %	22.00%	24.35%	18.64%	28.30%	27.02%	19.82%	27.56%	28.62%	24.05%	25.37%	22.39%	25.10%	24.24%
Net Profit	109	72	78	48	115	74	36	48	122	29	27	107	132
	6.54	4.36	4.81	2.97	7.06	4.55	2.24	2.96	7.51	1.81	1.67	6.58	8.11

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
	987	1,009	1,062	1,076	1,331	1,325	1,519	1,777	1,916	2,070	2,139
	760	767	843	856	1,048	1,001	1,272	1,524	1,578	1,750	1,816
Operating Profit	227	242	219	220	284	324	247	253	338	320	323
OPM %	23.00%	23.98%	20.63%	20.45%	21.30%	24.47%	16.25%	14.25%	17.66%	15.47%	15.10%
	40	44	51	51	83	97	79	55	103	106	117
Interest	1	1	1	1	3	3	3	4	4	4	5
Depreciation	34	35	35	33	37	38	37	39	40	54	59
Profit before Tax	232	250	234	236	325	380	285	266	398	368	392
Tax %	27.18%	25.11%	28.04%	27.41%	24.18%	22.59%	23.06%	24.36%	22.81%	25.58%	24.51%
Net Profit	169	187	168	172	247	294	220	201	307	274	296
EPS	9.50	10.52	9.47	9.84	14.34	17.32	13.01	12.09	18.87	16.81	—
Dividend Payout %	23.69%	21.39%	0.00%	0.00%	5.54%	0.00%	0.00%	0.00%	0.00%	29.75%	—

COMPOUNDED SALES GROWTH

10 Years:: 9%
5 Years:: 9%
3 Years:: 11%

COMPOUNDED PROFIT GROWTH

10 Years:: 6%
5 Years:: 2%
3 Years:: 8%

STOCK PRICE CAGR

10 Years:: 5%
5 Years:: 0%
3 Years:: -3%
1 Year:: -26%

RETURN ON EQUITY

10 Years:: 14%
5 Years:: 14%
3 Years:: 13%
Last Year:: 12%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	18	18	17	17	17	17	17	17	16	16
	1,059	1,246	1,245	1,416	1,525	1,705	1,932	1,964	2,081	2,271
	1	4	5	2	10	7	25	20	12	12
Trade Payables	82	75	97	77	118	77	136	178	185	202
	99	526	586	644	750	836	912	993	1,013	1,139
Total Liabilities	1,259	1,868	1,950	2,156	2,419	2,642	3,022	3,172	3,307	3,640
	671	674	670	678	670	685	701	695	676	848
Capital Work in Progress	17	3	10	12	24	19	104	198	261	136
	325	491	472	585	665	790	886	806	850	1,050
	130	136	160	173	209	213	304	323	383	368
	0	0	0	0	0	0	0	0	115	104
Cash & Bank	14	23	21	16	29	27	32	21	22	41
	101	539	618	692	822	907	995	1,129	1,000	1,094
Total Assets	1,259	1,868	1,950	2,156	2,419	2,642	3,022	3,172	3,307	3,640

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	226	226	216	175	323	304	241	242	221	310
Cash from Investing	-73	-144	20	-109	-85	-84	-147	4	-18	-199
Cash from Financing	-97	0	-169	-0	-142	-126	-10	-180	-202	-92
	1	10	-2	-6	12	-1	5	-11	1	19

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
PER SHARE
EPS (₹)	9.50	10.52	9.65	9.84	14.43	17.45	13.01	12.11	18.87	16.81
Book Value (₹)	60.53	71.06	72.38	82.16	90.18	102.02	115.44	119.39	128.81	140.48
Dividend per Share (₹)	2.25	2.25	0.00	0.00	0.80	0.00	0.00	0.00	0.00	5.00
Cash EPS (₹)	11.39	12.46	11.66	11.74	16.62	19.67	15.21	14.45	21.31	20.10
PROFITABILITY
Operating Margin %	26.43%	27.88%	24.57%	24.94%	26.82%	31.04%	20.81%	16.83%	17.16%	14.98%
Net Margin %	16.72%	17.88%	15.30%	15.56%	18.07%	21.69%	14.04%	10.97%	15.57%	12.80%
ROE %	16.84%	15.99%	13.33%	12.73%	16.59%	18.04%	11.97%	10.23%	15.06%	12.48%
ROCE %	23.25%	21.45%	18.62%	17.63%	22.06%	23.43%	15.66%	13.70%	19.71%	16.98%
	14.09%	11.97%	8.82%	8.35%	10.79%	11.64%	7.76%	6.49%	9.48%	7.88%
EFFICIENCY
Debtor Days	23	25	26	27	28	31	22	20	22	19
Inventory Days	45	46	49	55	51	57	60	62	65	64
Payable Days	87	85	89	92	84	86	74	88	103	97
	-19	-14	-15	-11	-5	2	9	-5	-15	-14
FINANCIAL HEALTH
Debt to Equity (x)	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x
Interest Coverage (x)	167.05x	178.52x	167.77x	166.02x	96.31x	112.82x	94.65x	66.79x	100.49x	82.92x
	3.21x	2.36x	2.05x	2.12x	2.21x	2.16x	2.04x	1.98x	2.21x	2.31x
GROWTH
Revenue Growth %	12.44%	2.24%	5.28%	1.29%	23.72%	-0.42%	14.60%	16.99%	7.83%	8.03%
Operating Profit Growth %	10.72%	9.24%	-7.29%	1.66%	33.26%	15.08%	-22.75%	-5.25%	43.17%	-3.60%
Net Profit Growth %	15.76%	10.75%	-10.02%	1.91%	43.86%	19.33%	-25.42%	-8.50%	52.84%	-10.92%
	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	55.75%	-10.92%
VALUATION
P/E (x)	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	22.50x	23.46x
P/B (x)	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	3.30x	2.81x
Dividend Yield %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	1.27%
	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	15.60x	14.98x

Shareholding Pattern

Numbers in percentages

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	69.66	69.66	69.66	69.66	69.66	69.66	69.66	69.66	69.66
	2.51	2.62	2.67	2.56	2.41	2.44	2.32	2.40	1.40
	6.72	6.03	6.08	6.37	7.17	6.81	6.27	6.29	6.31
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	21.10	21.70	21.59	21.42	20.76	21.10	21.75	21.65	22.63

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-04

Copy of Newspaper Publication

2026-09-04 - FDC Limited has informed the Exchange about Copy of Newspaper Publication

2026-09-01

Record Date

2026-09-01 - FDC Limited has informed the Exchange that Record date for the purpose of Meeting is 16-Sep-2026.

2026-09-01

Shareholders meeting

2026-09-01 - FDC Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 24, 2026

2026-09-01

Copy of Newspaper Publication

2026-09-01 - FDC Limited has informed the Exchange about the newspaper publication in respect of the 86th AGM.

2026-08-27

General Updates

2026-08-27 - FDC Limited has informed the Exchange about Interim Stay received from The Honourable High Court of Delhi, New Delhi

2026-08-13

General Updates

2026-08-13 - FDC Limited has informed the Exchange about Marketing Authorisation received by its subsidiary, FDC International Ltd, from MHRA, UK, for Atropine 1.0% w/v Eye Drops, Solution.

2026-08-05

Press Release

2026-08-05 - FDC Limited has informed the Exchange regarding a press release dated August 05, 2026, titled "Press Release Q1 FY 2026-2027 Results".

2026-08-05

Outcome of Board Meeting

2026-08-05 - FDC Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

2026-07-27

Certificate under SEBI (Depositories and Participants) Regulations, 2018

2026-07-27 - FDC Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

News

Recent coverage and analyst commentary for FDC

Loading news…

🤖

AI Stock Analyst

FDC Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account

Name

SUNPHARMA

1899.00

37.67

455633.71

0.84

2901.23

26.53

15299.88

10.98

19.11

28.81

DIVISLAB

9100.00

82.59

241576.41

0.33

902.00

65.50

3080.00

27.80

21.51

40.75

TORNTPHARM

4850.00

84.58

184478.41

0.78

566.00

3.28

4921.00

57.32

19.27

33.81

CIPLA

1385.00

33.19

111888.39

0.94

785.55

-39.18

7119.28

4.13

16.00

16.73

ZYDUSLIFE

1121.00

24.78

111820.18

0.09

990.20

-34.90

8017.00

23.97

21.39

24.54

LAURUSLABS

1840.00

90.93

99417.45

0.11

362.07

123.94

2026.31

29.10

18.20

31.50

LUPIN

2111.00

17.46

96528.82

0.85

1416.98

16.01

8276.89

34.28

28.86

29.59

DRREDDY

1154.00

29.89

96322.06

0.69

435.60

-69.10

8099.80

-5.21

13.75

10.63

MANKIND

2328.55

47.09

96179.61

0.04

574.09

29.12

4030.59

12.89

13.24

26.30

AUROPHARMA

1653.30

25.62

95127.23

0.24

1032.03

25.22

9150.35

17.44

12.76

20.54

GLENMARK

2427.00

38.10

68495.93

0.10

482.83

927.88

4018.48

31.35

20.35

20.03

FDC

342.65

19.07

5578.69

0.00

132.49

9.18

667.69

2.97

16.52

21.42

Jun 2023

Sep 2023

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

530

480

452

454

624

505

459

482

642

462

458

564

655

410

401

370

396

482

433

413

429

501

427

408

453

528

Operating Profit

120

142

141

112

127

OPM %

22.64%

16.41%

18.11%

12.73%

22.70%

14.33%

10.01%

10.96%

22.00%

7.56%

10.83%

19.78%

19.38%

Interest

Depreciation

Profit before Tax

139

158

161

143

174

Tax %

22.00%

24.35%

18.64%

28.30%

27.02%

19.82%

27.56%

28.62%

24.05%

25.37%

22.39%

25.10%

24.24%

Net Profit

109

115

122

107

132

6.54

4.36

4.81

2.97

7.06

4.55

2.24

2.96

7.51

1.81

1.67

6.58

8.11

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

TTM

987

1,009

1,062

1,076

1,331

1,325

1,519

1,777

1,916

2,070

2,139

760

767

843

856

1,048

1,001

1,272

1,524

1,578

1,750

1,816

Operating Profit

227

242

219

220

284

324

247

253

338

320

323

OPM %

23.00%

23.98%

20.63%

20.45%

21.30%

24.47%

16.25%

14.25%

17.66%

15.47%

15.10%

103

106

117

Interest

Depreciation

Profit before Tax

232

250

234

236

325

380

285

266

398

368

392

Tax %

27.18%

25.11%

28.04%

27.41%

24.18%

22.59%

23.06%

24.36%

22.81%

25.58%

24.51%

Net Profit

169

187

168

172

247

294

220

201

307

274

296

EPS

9.50

10.52

9.47

9.84

14.34

17.32

13.01

12.09

18.87

16.81

—

Dividend Payout %

23.69%

21.39%

0.00%

5.54%

0.00%

29.75%

—

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Equity Capital

1,059

1,246

1,245

1,416

1,525

1,705

1,932

1,964

2,081

2,271

Trade Payables

118

136

178

185

202

526

586

644

750

836

912

993

1,013

1,139

Total Liabilities

1,259

1,868

1,950

2,156

2,419

2,642

3,022

3,172

3,307

3,640

671

674

670

678

670

685

701

695

676

848

Capital Work in Progress

104

198

261

136

325

491

472

585

665

790

886

806

850

1,050

130

136

160

173

209

213

304

323

383

368

115

104

Cash & Bank

101

539

618

692

822

907

995

1,129

1,000

1,094

Total Assets

1,259

1,868

1,950

2,156

2,419

2,642

3,022

3,172

3,307

3,640

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

226

216

175

323

304

241

242

221

310

Cash from Investing

-73

-144

-109

-85

-84

-147

-18

-199

Cash from Financing

-97

-169

-0

-142

-126

-10

-180

-202

-92

-2

-6

-1

-11

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

PER SHARE

EPS (₹)

9.50

10.52

9.65

9.84

14.43

17.45

13.01

12.11

18.87

16.81

Book Value (₹)

60.53

71.06

72.38

82.16

90.18

102.02

115.44

119.39

128.81

140.48

Dividend per Share (₹)

2.25

0.00

0.80

0.00

5.00

Cash EPS (₹)

11.39

12.46

11.66

11.74

16.62

19.67

15.21

14.45

21.31

20.10

PROFITABILITY

Operating Margin %

26.43%

27.88%

24.57%

24.94%

26.82%

31.04%

20.81%

16.83%

17.16%

14.98%

Net Margin %

16.72%

17.88%

15.30%

15.56%

18.07%

21.69%

14.04%

10.97%

15.57%

12.80%

ROE %

16.84%

15.99%

13.33%

12.73%

16.59%

18.04%

11.97%

10.23%

15.06%

12.48%

ROCE %

23.25%

21.45%

18.62%

17.63%

22.06%

23.43%

15.66%

13.70%

19.71%

16.98%

14.09%

11.97%

8.82%

8.35%

10.79%

11.64%

7.76%

6.49%

9.48%

7.88%

EFFICIENCY

Debtor Days

Inventory Days

Payable Days

103

-19

-14

-15

-11

-5

-15

-14

FINANCIAL HEALTH

Debt to Equity (x)

0.00x

Interest Coverage (x)

167.05x

178.52x

167.77x

166.02x

96.31x

112.82x

94.65x

66.79x

100.49x

82.92x

3.21x

2.36x

2.05x

2.12x

2.21x

2.16x

2.04x

1.98x

2.21x

2.31x

GROWTH

Revenue Growth %

12.44%

2.24%

5.28%

1.29%

23.72%

-0.42%

14.60%

16.99%

7.83%

8.03%

Operating Profit Growth %

10.72%

9.24%

-7.29%

1.66%

33.26%

15.08%

-22.75%

-5.25%

43.17%

-3.60%

Net Profit Growth %

15.76%

10.75%

-10.02%

1.91%

43.86%

19.33%

-25.42%

-8.50%

52.84%

-10.92%

0.00%

55.75%

-10.92%

VALUATION

P/E (x)

0.00x

22.50x

23.46x

P/B (x)

0.00x

3.30x

2.81x

Dividend Yield %

0.00%

1.27%

0.00x

15.60x

14.98x

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

69.66

2.51

2.62

2.67

2.56

2.41

2.44

2.32

2.40

1.40

6.72

6.03

6.08

6.37

7.17

6.81

6.27

6.29

6.31

Government

0.00

21.10

21.70

21.59

21.42

20.76

21.10

21.75

21.65

22.63

FDC Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI

FDC Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI